Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis.
Journal
Neuro-oncology advances
ISSN: 2632-2498
Titre abrégé: Neurooncol Adv
Pays: England
ID NLM: 101755003
Informations de publication
Date de publication:
Historique:
entrez:
14
7
2021
pubmed:
15
7
2021
medline:
15
7
2021
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1093/noajnl/vdaa082.].
Identifiants
pubmed: 34258581
doi: 10.1093/noajnl/vdab095
pii: vdab095
pmc: PMC8272530
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
vdab095Commentaires et corrections
Type : ErratumFor
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.